Can your genes predict breast cancer drug reactions?
NCT ID NCT00896376
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This study analyzed blood samples from 49 women with metastatic breast cancer to find genetic markers linked to how they respond to trastuzumab (Herceptin). The goal was to better understand side effects like heart toxicity and allergic reactions, as well as treatment effectiveness. No new treatment was tested; instead, researchers observed existing patients to gather knowledge for future personalized care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
Conditions
Explore the condition pages connected to this study.